| Financial Year |
March 31 2023 |
| Monetary Funds |
325,595,043.46 |
| Held-for-trading Financial Assets |
211,375,555.56 |
| Notes Receivable |
20,558,455.91 |
| Accounts Receivable |
239,977,163.98 |
| Advances to Suppliers |
2,088,949.02 |
| Other Receivables |
9,121,417.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,350,249.74 |
| Dividend Receivable |
-- |
| Inventories |
196,377,673.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,395,509.71 |
| Total Current Assets |
1,040,509,892.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
78,935,270.19 |
| Under-construction Projects |
17,562.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,018,919.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,009,460.30 |
| Deferred Income Tax Assets |
7,205,680.85 |
| Other Non-Current Assets |
3,438,173.11 |
| Sub-Total of Non-Current Assets |
156,020,544.79 |
| Total Assets |
1,196,530,437.30 |
| Short-Term Loans |
3,396,070.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,030,914.96 |
| Accounts Payable |
126,790,856.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,724,999.85 |
| Taxes Payable |
5,189,924.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,909,194.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
584,360.03 |
| Other Current Liabilities |
1,043,386.98 |
| Sub-Total of Current Liabilities |
243,344,211.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
56,333.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
401,574.82 |
| Total Liabilities |
243,745,786.46 |
| Paid-In Capital(Or Share Stock) |
326,019,466.00 |
| Capital Surplus |
133,058,454.39 |
| Surplus Reserve |
58,118,829.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
447,731,215.72 |
| Minority Stockholder's Interest |
-11,980,580.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
964,765,231.54 |
| Owner's Equity（Stockholder's Equity） |
952,784,650.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,196,530,437.30 |
